Company Profiles

driven by the PitchBook Platform

ArraVasc

Description

Developer of medical devices for the treatment of Coronary Artery Disease (CAD) and bifurcation vascular disease. The company develops drug eluting ostium protection devices for the treatment of coronary artery lesions located at a bifurcation and ostium.

2004

Founded

PRIVATE

Status

11-50

Employees

2ndary - Private

Latest Deal Type

$57.9M

Total Amount Raised

6

Investors

Description

Developer of medical devices for the treatment of Coronary Artery Disease (CAD) and bifurcation vascular disease. The company develops drug eluting ostium protection devices for the treatment of coronary artery lesions located at a bifurcation and ostium.

Website:

www.arravasc.com

Formerly Known As

Cappella Medical Devices

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Other Devices and Supplies

Primary Office

2 Ballybrit Business Park Galway H91DT7CIreland
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore ArraVasc's full profile, request a free trial.

ArraVasc Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

ArraVasc Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
ACT Venture CapitalVenture CapitalMinority000 0000000 0000
Enterprise IrelandVenture CapitalMinority000 0000000 0000
Fountain Healthcare PartnersVenture CapitalMinority000 0000000 0000
Kreos CapitalGrowth/ExpansionMinority000 0000000 0000
Mitsui Global InvestmentCorporate Venture CapitalMinority000 0000000 0000
ACT Venture Capital Venture Capital
Enterprise Ireland Venture Capital
Fountain Healthcare Partners Venture Capital
Kreos Capital Growth/Expansion
Mitsui Global Investment Corporate Venture Capital

ArraVasc Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Jonathan AkehurstChief Executive Officer & Board Member
David KellyChief Financial Officer & Board Member
Paul ThorntonHead, Operations
Cristiano MeneghinEuropean Business Development Manager
Andrew JonesNon-Executive Director
Jonathan Akehurst Chief Executive Officer & Board Member
David Kelly Chief Financial Officer & Board Member
Paul Thornton Head, Operations
Cristiano Meneghin European Business Development Manager
Andrew Jones Non-Executive Director

ArraVasc Board Members (5)

NameRepresentingRoleSinceContact
Info
David KellyArraVascChief Financial Officer & Board Member000 0000
Debbie RennickACT Venture CapitalDirector000 0000
Eamonn HobbsSelfBoard Member000 0000
Jonathan AkehurstArraVascChief Executive Officer & Board Member000 0000
Masashi KiyomineMitsui Global InvestmentInvestment Director000 0000
David Kelly Chief Financial Officer & Board Member ArraVasc
Debbie Rennick Director ACT Venture Capital
Eamonn Hobbs Board Member Self
Jonathan Akehurst Chief Executive Officer & Board Member ArraVasc
Masashi Kiyomine Investment Director Mitsui Global Investment
Request full access to PitchBook